Novai

Description: Novai commercializes DARC Tech, an AI-powered retinal biomarker for AMD & glaucoma trials, aiding in patient stratification & drug efficacy assessment.

Country: UK

Based in: Reading

Founded: 2020

Funding Stage: Series A/B

Tags: ['Artificial Intelligence', 'Biotechnology', 'Clinical Trials']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.